OBSIDIAN THERAPEUTICS Trademark
Trademark Overview
On Tuesday, January 24, 2023, a trademark application was filed for OBSIDIAN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OBSIDIAN THERAPEUTICS trademark a serial number of 97765729. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, June 27, 2024. This trademark is owned by Obsidian Therapeutics, Inc.. The OBSIDIAN THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, immunotherapy, regenerative medicine, infectious disease, and the prevention and treatment of cardiovascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculoskeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, dermatological disorders and gastroenterological disorders
General Information
| Serial Number | 97765729 |
| Word Mark | OBSIDIAN THERAPEUTICS |
| Filing Date | Tuesday, January 24, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Thursday, June 27, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 28, 2023 |
Trademark Statements
| Description of Mark | The mark consists of the wording "OBSIDIAN THERAPEUTICS" to the right of a seven-sided heptagon shape with lines within the heptagon that create three triangular elements surrounding a quadrilateral. |
| Goods and Services | Pharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, immunotherapy, regenerative medicine, infectious disease, and the prevention and treatment of cardiovascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculoskeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, dermatological disorders and gastroenterological disorders |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 13, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Obsidian Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02138 |
| Party Name | Obsidian Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02138 |
Trademark Events
| Event Date | Event Description |
| Friday, January 27, 2023 | NEW APPLICATION ENTERED |
| Monday, February 13, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 14, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, September 14, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, September 20, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, September 20, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, September 20, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, September 20, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Friday, October 20, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 8, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 28, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 28, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 23, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, June 27, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 27, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 27, 2024 | SOU EXTENSION 1 FILED |
| Thursday, June 27, 2024 | SOU EXTENSION 1 GRANTED |
| Thursday, December 5, 2024 | SOU TEAS EXTENSION RECEIVED |
